AT
AdvisorShares Trust disclosed a 6.8% stake in PBM
AdvisorShares Trust reported owning 6.8% of Psyence Biomedical Ltd. (PBM) (258,538 shares) in a Schedule 13G filed Oct 5, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.